PT1003528E - Metodo para aumentar a biodisponibilidade da fexofenadina e seus derivados - Google Patents

Metodo para aumentar a biodisponibilidade da fexofenadina e seus derivados

Info

Publication number
PT1003528E
PT1003528E PT98935892T PT98935892T PT1003528E PT 1003528 E PT1003528 E PT 1003528E PT 98935892 T PT98935892 T PT 98935892T PT 98935892 T PT98935892 T PT 98935892T PT 1003528 E PT1003528 E PT 1003528E
Authority
PT
Portugal
Prior art keywords
biodisponibility
fexofenadine
derivatives
increasing
Prior art date
Application number
PT98935892T
Other languages
English (en)
Inventor
Gail H Hurst
Kin-Kai Hwang
Dennis H Giesing
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of PT1003528E publication Critical patent/PT1003528E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/745Polymers of hydrocarbons
    • A61K31/75Polymers of hydrocarbons of ethene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
PT98935892T 1997-08-14 1998-07-21 Metodo para aumentar a biodisponibilidade da fexofenadina e seus derivados PT1003528E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91156397A 1997-08-14 1997-08-14

Publications (1)

Publication Number Publication Date
PT1003528E true PT1003528E (pt) 2003-02-28

Family

ID=25430473

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98935892T PT1003528E (pt) 1997-08-14 1998-07-21 Metodo para aumentar a biodisponibilidade da fexofenadina e seus derivados

Country Status (30)

Country Link
EP (1) EP1003528B1 (pt)
JP (1) JP4295913B2 (pt)
KR (1) KR100522985B1 (pt)
CN (1) CN1143680C (pt)
AR (1) AR018505A1 (pt)
AT (1) ATE224721T1 (pt)
AU (1) AU725965C (pt)
BR (1) BR9811937A (pt)
CA (1) CA2301267C (pt)
CZ (1) CZ293666B6 (pt)
DE (1) DE69808303T2 (pt)
DK (1) DK1003528T3 (pt)
EE (1) EE04263B1 (pt)
ES (1) ES2179523T3 (pt)
HK (1) HK1025901A1 (pt)
HU (1) HU226823B1 (pt)
ID (1) ID24463A (pt)
IL (1) IL134521A (pt)
NO (1) NO325148B1 (pt)
NZ (1) NZ502133A (pt)
OA (1) OA11287A (pt)
PL (1) PL191607B1 (pt)
PT (1) PT1003528E (pt)
RU (1) RU2197967C2 (pt)
SK (1) SK283868B6 (pt)
TR (1) TR200000419T2 (pt)
TW (1) TWI240633B (pt)
UA (1) UA64765C2 (pt)
WO (1) WO1999008690A1 (pt)
ZA (1) ZA987221B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0812195T3 (da) 1995-02-28 2003-03-03 Aventis Pharma Inc Farmaceutisk sammensætning til piperidinoalkanolforbindelser
CN1159012C (zh) * 1997-08-26 2004-07-28 阿旺蒂斯制药公司 用于组合哌啶子基烷醇-减充血剂的药物组合物
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
BR0306329A (pt) * 2002-05-29 2005-04-26 Aventis Pharmaceuticals Holdin Método de tratamento de asma
JP2008120684A (ja) * 2005-03-07 2008-05-29 Kumamoto Univ 抗アレルギー薬
KR101106374B1 (ko) 2009-06-05 2012-01-19 민병욱 고체연료에 의한 가연성 가스 발생 장치
KR101117014B1 (ko) * 2009-09-09 2012-06-14 민병욱 부패성 폐기물의 바이오매스 처리에 의한 폐자원 재활용 방법 및 장치
CN101843616B (zh) * 2010-06-04 2011-07-27 西安万隆制药有限责任公司 一种盐酸非索非那定与微晶纤维素组合物及其制备方法
RU2453315C2 (ru) * 2010-08-17 2012-06-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения аллергических заболеваний
CN103687592A (zh) 2011-05-20 2014-03-26 安万特药物公司 包含非索非那定的药物组合物
RU2504018C1 (ru) * 2012-05-28 2014-01-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения и социального развития Российской Федерации Способ моделирования состояния индукции функциональной активности гликопротеина-р финастеридом в эксперименте
RU2553362C1 (ru) * 2014-01-09 2015-06-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ моделирования состояния ингибирования функциональной активности гликопротеина-р линестренолом в эксперименте
CN104188998A (zh) * 2014-09-18 2014-12-10 中山大学 一种柚皮苷与盐酸非索非那丁药物组合物及其制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
WO1996040192A1 (en) * 1995-06-07 1996-12-19 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
WO1996040792A1 (en) * 1995-06-07 1996-12-19 Novo Nordisk A/S Modification of polypeptides

Also Published As

Publication number Publication date
EE200000069A (et) 2000-10-16
CZ293666B6 (cs) 2004-06-16
IL134521A0 (en) 2001-04-30
EE04263B1 (et) 2004-04-15
ES2179523T3 (es) 2003-01-16
AU725965C (en) 2004-04-22
AU8505098A (en) 1999-03-08
HU226823B1 (hu) 2009-11-30
JP2001515041A (ja) 2001-09-18
TR200000419T2 (tr) 2000-09-21
DE69808303D1 (de) 2002-10-31
SK1842000A3 (en) 2000-08-14
JP4295913B2 (ja) 2009-07-15
NZ502133A (en) 2002-03-28
RU2197967C2 (ru) 2003-02-10
CZ2000522A3 (cs) 2000-09-13
KR100522985B1 (ko) 2005-10-21
DE69808303T2 (de) 2003-05-22
WO1999008690A1 (en) 1999-02-25
ZA987221B (en) 1999-02-15
TWI240633B (en) 2005-10-01
ID24463A (id) 2000-07-20
EP1003528A1 (en) 2000-05-31
UA64765C2 (uk) 2004-03-15
AR018505A1 (es) 2001-11-28
CN1267221A (zh) 2000-09-20
BR9811937A (pt) 2000-09-05
CA2301267A1 (en) 1999-02-25
OA11287A (en) 2003-10-22
DK1003528T3 (da) 2003-02-03
KR20010022845A (ko) 2001-03-26
EP1003528B1 (en) 2002-09-25
CA2301267C (en) 2004-07-13
SK283868B6 (sk) 2004-03-02
HUP0003189A2 (en) 2001-03-28
PL338579A1 (en) 2000-11-06
CN1143680C (zh) 2004-03-31
NO325148B1 (no) 2008-02-11
NO20000706L (no) 2000-04-13
ATE224721T1 (de) 2002-10-15
NO20000706D0 (no) 2000-02-11
HUP0003189A3 (en) 2001-04-28
AU725965B2 (en) 2000-10-26
IL134521A (en) 2005-07-25
HK1025901A1 (en) 2000-12-01
PL191607B1 (pl) 2006-06-30

Similar Documents

Publication Publication Date Title
NO965343D0 (no) Rålegemiddelholdig for
DK0796846T3 (da) 2-Aryl-substituerede pyridiner
DK0946542T3 (da) Indan- eller dihydroindolderivater
CY2004002I1 (el) Παραγωγο ανδροστενονης
NO994791D0 (no) Nikotinamid-derivater
NO2008002I1 (no) Protiokonazol og salter derav
PT983251E (pt) Derivados piperazinil-benzil-tetrazole anti-inflamatorios e seus intermediarios
ATE278695T1 (de) Piperidinderivate
EE200100133A (et) Pulverisaator ja pulverisatsioonimeetod
PT1003528E (pt) Metodo para aumentar a biodisponibilidade da fexofenadina e seus derivados
BR9503761A (pt) Bucha de mancal e um método para a fabricação de uma bucha de mancal
BR9500228A (pt) Caixa para cigarros
PT1028960E (pt) Processo para a preparacao de derivados de tiazolidinodiona
PT957690E (pt) Metodo para a producao de alimentos para salmonideos e alimentos para salmonideos
FI942298A0 (fi) Menetelmä ja sovitelma tilaelementtien siirtämiseksi
BR9608279A (pt) Armario para armazanagem e montagem
NO965233D0 (no) Deacetoksytaksol-derivat
NO970144L (no) Trifluormetylkinolinkarboksylsyre-derivat
ATE182133T1 (de) Naphtochinonderivate
PT924196E (pt) Procedimento para a alquilacao de derivados de alquil- ou benzilciano em presenca de trialquilaminas ou -fosfinas
NO992302D0 (no) Piperidin-derivater
KR950023859U (ko) 왕복회전간판
PT1077987E (pt) Propcesso para a preparacao de 4-desoxieritromicinas a e b
FR2723196B1 (fr) Actionneur micrometrique
KR960008337U (ko) 자동완충 경첩